Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer – OncLive
OncLive |
Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer
OncLive As with other solid tumors, researchers are now exploring both BRAF/MEK inhibitor combinations and PD-1 therapy in the field of thyroid cancer for patients who are refractory to radioactive-iodine treatment, according to Gregory Daniels, MD, PhD, who … |
